Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2008 1
2010 1
2011 1
2012 1
2015 1
2018 1
2019 2
2020 3
2021 3
2022 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC).
Muszbek N, Evans R, Remak E, Brennan VK, Colaone F, Shergill S, Ross P, Mullan D. Muszbek N, et al. Among authors: remak e. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):147-154. doi: 10.1080/14737167.2021.1973892. Epub 2021 Sep 6. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34488517
The economic burden of metastatic breast cancer in Spain.
Bermejo de Las Heras B, Cortes Ramon Y Cajal J, Galve Calvo E, de la Haba Rodriguez J, Garcia Mata J, Moreno Anton F, Pelaez Fernandez I, Rodriguez-Lescure A, Rodriguez Sanchez CA, Ruiz-Borrego M, Remak E, Barra M, Rivero M, Soto Alvarez J. Bermejo de Las Heras B, et al. Among authors: remak e. Eur J Hosp Pharm. 2020 Jan;27(1):19-24. doi: 10.1136/ejhpharm-2017-001453. Epub 2018 Jul 30. Eur J Hosp Pharm. 2020. PMID: 32064084 Free PMC article.
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data.
Remák E, Hawkins N, Jones T, Otley M, Twigger R, Prince M. Remák E, et al. Eur J Cancer. 2021 Oct;156 Suppl 1:S18. doi: 10.1016/S0959-8049(21)00659-6. Eur J Cancer. 2021. PMID: 34649645 No abstract available.
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M. Torres A, et al. Among authors: remak e. Clinicoecon Outcomes Res. 2022 Mar 18;14:149-161. doi: 10.2147/CEOR.S329494. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35330907 Free PMC article.
18 results